http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9211281

Outgoing Links

Predicate Object
contentType Clinical Trial|Clinical Trial, Phase I|Comparative Study|Journal Article|Randomized Controlled Trial|Research Support, U.S. Gov't, P.H.S.
endingPage 867
issn 1538-7755
1055-9965
issueIdentifier 5
pageRange 861-867
publicationName Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
startingPage 861
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_83d4c3f14b3c673f243493d608b426e0
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_04a927cf22b064c2a2db63626aa8c8ad
bibliographicCitation Hess LM, Krutzsch MF, Guillen J, Chow HH, Einspahr J, Batta AK, Salen G, Reid ME, Earnest DL, Alberts DS. Results of a phase I multiple-dose clinical study of ursodeoxycholic Acid. Cancer Epidemiol Biomarkers Prev. 2004 May;13(5):861–7. PMID: 15159320.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_463d708a0ce06f47c87727a3a377faf0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c08aecffcbf2d5524ccf2e77e658996e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ba0bf758a93c5cbc86c9dbadf36d7e40
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d122ce871780527a725ecc0ec77c3606
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7e788c925be8828502f98fa4e26d53d8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d008372b19b40b233d3846bef4aaa253
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f3c16d9a35d0f9f5c25f6d5f9db2d18f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ddf9c010ee817fba0958242ea438994f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5e64a3acc13837c5b8ed48ee85ba40d1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d61de631f899bc8885564843eb80aae0
date 2004-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/15159320
https://doi.org/10.1158/1055-9965.861.13.5
isPartOf https://portal.issn.org/resource/ISSN/1538-7755
https://portal.issn.org/resource/ISSN/1055-9965
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2299
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Results of a Phase I Multiple-Dose Clinical Study of Ursodeoxycholic Acid
discusses http://id.nlm.nih.gov/mesh/M0022413
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D014580Q000493
http://id.nlm.nih.gov/mesh/D014580Q000008
hasSubjectTerm http://id.nlm.nih.gov/mesh/D001682
http://id.nlm.nih.gov/mesh/D012016
http://id.nlm.nih.gov/mesh/D004305
http://id.nlm.nih.gov/mesh/D015179Q000517
http://id.nlm.nih.gov/mesh/D000367
http://id.nlm.nih.gov/mesh/D000369
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D004334
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D051381
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D011336
http://id.nlm.nih.gov/mesh/D012737
http://id.nlm.nih.gov/mesh/D000293
http://id.nlm.nih.gov/mesh/D004311
http://id.nlm.nih.gov/mesh/D020714
http://id.nlm.nih.gov/mesh/D019540
http://id.nlm.nih.gov/mesh/D000328
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D000284
http://id.nlm.nih.gov/mesh/D000818
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24883735
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11431
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439520
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6799
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31401
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9672
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID303
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_22031912196251d3068521dae26ea414
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222528
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128448066
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129182106

Total number of triples: 69.